Partnering supports novel DEL-screening capabilities Chemspace/Enamine positioned to augment product and service offerings Orogen to gain potential novel therapeutic small molecules Orogen Therapeutic ...

AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and ...

A resonance effect can significantly affect how a three-atom molecule cools down when excited, RIKEN physicists have found.

The small molecule clinical candidate ... "It demonstrates our ability to translate novel science into programs that attract world-class partners and progress into the clinic. With additional first-in ...

Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease ...

A team of NYU chemists and physicists are using cutting-edge tools—holographic microscopy and super-resolution imaging—to ...

New England Biolabs (NEB ®) today announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to ...

The abstracts accepted for mini oral presentations include updated efficacy and safety data from the Phase 2b REZILIENT1 ...

The Huck Institutes of the Life Sciences at Penn State has secured a major new asset in structural biology and mechanobiology ...

A team of NYU chemists and physicists are using cutting-edge tools—holographic microscopy and super-resolution imaging—to ...